Minnesota’s PFAS Product Reporting Rule is now finalized, and the timeline to act is already underway.
Established under Amara’s Law, the Minnesota Pollution Control Agency (MPCA) finalized its PFAS reporting rule on December 8, 2025. This regulation requires manufacturers to report intentionally added PFAS in products sold, offered for sale, or distributed in Minnesota by July 1, 2026, with annual updates thereafter.
For organizations across the supply chain, this introduces new complexities in data collection, supplier engagement, compliance documentation and reporting through the PRISM portal.
Why Attend?
This session is designed for manufacturers, suppliers and distributors navigating PFAS product reporting requirements and evolving regulatory expectations.
- Clear guidance on immediate compliance actions
- Practical strategies for managing PFAS data across the supply chain
- Insights into using the PRISM reporting system effectively
- Best practices for documentation, due diligence and risk management
- Understanding of how Minnesota requirements align with broader PFAS regulations
Who Should Attend?
- Manufacturers and distributors selling products in Minnesota
- Supply chain and procurement leaders
- EHS and compliance professionals
- Regulatory affairs teams
- Product stewardship and sustainability leaders
Join TRC for a focused webinar designed to help you understand what actions are required now and how to prepare for what comes next.
Related Services
Meet Our Experts
Mark Robinson, PE, CHMM, CPEA
EHS&S Market Director and Chemical Reporting Expert
Mark brings over 30 years of experience in EHS consulting and regulatory compliance across multiple industries. His expertise includes complex regulatory reporting, chemical data management and large-scale compliance programs across sectors such as oil and gas, manufacturing, pulp and paper and metals.
Dr. David Brew
Senior Toxicologist and PFAS Risk Specialist
David specializes in human health risk assessments related to environmental contaminants, with a strong focus on PFAS. His work includes evaluating exposure risks, supporting regulatory analysis and interpreting scientific data to guide compliance and policy decisions.
Partager nos perspectives
Nos praticiens partagent leurs idées et leurs points de vue sur les tendances et les défis qui façonnent le marché.
PFAS in Consumer Products: Assessing the Risk of Dermal Exposures
juillet 17, 2025
Products, such as bandages, baby wipes and feminine care products, may contain trace levels of PFAS due to intentional use or cross-contamination, which has prompted recent concerns about skin absorption and long-term health effects.
Understanding PFAS Contamination Fate & Transport and Impacts of Forensic Evaluation
mars 9, 2026
Watch TRC’s expert session to explore the real-world challenges that often hinder remediation success and the proven strategies that help maintain both technical strength and strategic alignment.
Seeing Beyond the Summary: Why PFAS Data Evaluation Must Go Deeper Than Level 2
octobre 1, 2025
False positives and negatives in PFAS lab data can mislead decisions. Learn why Level 4 data review is essential.